LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemia
Published in: | Annals of hematology. - Springer Berlin Heidelberg, 1955. - 99(2020), 10 vom: 24. Aug., Seite 2343-2349 |
---|---|
Main Author: | |
Other Authors: | |
Format: | electronic Article |
Language: | English |
Published: |
2020
|
ISSN: | 1432-0584 |
External Sources: | lizenzpflichtig |
External Sources: lizenzpflichtig
Request interlibrary loan at ifa